We didn’t set out to build a stent. We set out to solve a moment no one forgets.
pa·ten·cy
The condition of being open, expanded, or unobstructed.
Peytant was founded by medtech veterans with a mission to give clinicians tools they can trust in the toughest scenarios.
Our proprietary use of human amnion, a form of placental tissue, powers a new generation of amnion-derived membrane coverings that help reduce the body’s natural foreign body response, often associated with implants used to treat luminal disease.
Our Mission
To fundamentally transform the treatment of all luminal diseases by increasing patency.
Executive Team
-
John Schorgl
FOUNDER / DIRECTOR
Schneider (Pfizer), Boston Scientific, Baxter Int, SuperDimension, Coulter -
Steve Healy
FOUNDER/DIRECTOR
St. Jude Medical, Schneider (Pfizer), Zimmer Spine, Disc Dynamics, ActivOrtho -
Craig Walker MD
CHIEF MEDICAL OFFICER
Harvard Brigham & Women's, Cardiovascular Institute South -
F. Edwin Froelich MD, JD
MEDICAL DIRECTOR
Vanderbilt School Med, Georgetown Law -
JD Simpson
CHIEF COMMERCIAL OFFICER
Insightec, Certus, Avinger, FoxHollow -
Lou Ellis
VP QUALITY, REGULATORY & PROJECT MANAGEMENT
Boston Scientific, Greatbatch (Integer), Smiths Medical -
Brian Brown
VP R&D
Cogentix, OvaGene, Boston Scientific -
Dale Brady
DIRECTOR OF OPERATIONS
Endogenix, Osprey Medical, Anulex -
Elizabeth Burnett
VP MARKETING
Medtronic, St. Jude Medical, Miromatrix, Vomaris -
Stacey Bremer
DIRECTOR OF REGULATORY AFFAIRS & QUALITY ASSURANCE
Boston Scientific, NAMSA, Abbott